Purple Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Purple Biotech and other ETFs, options, and stocks.

About PPBT

Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3. 

CEO
Gil Efron
CEOGil Efron
Employees
9
Employees9
Headquarters
Rehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded
1968
Founded1968
Employees
9
Employees9

PPBT Key Statistics

Market cap
5.86M
Market cap5.86M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
18.83K
Average volume18.83K
High today
$4.20
High today$4.20
Low today
$3.81
Low today$3.81
Open price
$4.00
Open price$4.00
Volume
6.25K
Volume6.25K
52 Week high
$30.50
52 Week high$30.50
52 Week low
$3.70
52 Week low$3.70

PPBT News

TipRanks 1d
Purple Biotech regains compliance with Nasdaq

Purple Biotech (PPBT) received confirmation from the Listing Qualifications Department of Nasdaq that the company had regained compliance with the minimum bid p...

TipRanks 1d
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price

Purple Biotech ( (PPBT) ) has shared an announcement. On March 17, 2026, Purple Biotech announced it had regained compliance with Nasdaq’s minimum bid price re...

TipRanks 5d
Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright

H.C. Wainwright analyst Emily Bodnar lowered the firm’s price target on Purple Biotech (PPBT) to $30 from $34 and keeps a Buy rating on the shares. The company...

More PPBT News

Nasdaq 5d
Purple Biotech CEO Gil Efron To Step Down For Health Reasons

(RTTNews) - Purple Biotech Ltd. (PPBT), a clinical-stage pharmaceutical company, Friday announced that its Chief Executive Officer, Gil Efron will step down fro...

Purple Biotech CEO Gil Efron To Step Down For Health Reasons
TipRanks 5d
Purple Biotech CEO Gil Efron to step down in August

Purple Biotech (PPBT) announced that Gil Efron, CEO, will step down from his role as CEO effective August 2026. Efron will remain actively involved with the Com...

TipRanks 5d
Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year

“In 2025, we focused on the CAPTN-3 platform and the value it can generate for patients and shareholders, naming a second tri-specific antibody from the platfor...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.